EUVIMEDEUVIMED entdecken
Multizentrische Studie

Reliability of Central Vein Sign Imaging With 3T FLAIR* in a Multicenter Study

Melissa Lynne Martin, Quy Cao, Elaina Luskin, Brian Renner, Lynn Daboul, Carly M O'Donnell, Paulo Rodrigues iD, John Derbyshire, Christina J Azevedo, Amit Bar-Or, Eduardo Caverzasi, Peter Calabresi iD und 18 weitere

Journal of Neuroimaging · 2025

DOI: 10.1111/jon.70011 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Neuroimaging, 2025. Verfasst von Melissa Lynne Martin und 29 weiteren Autor:innen. Beteiligte Einrichtung: Penn Statistics in Imaging and Visualization Endeavor, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Multiple Sclerosis, Magnetic Resonance Imaging, Cerebral Veins, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose The central vein sign (CVS) is a diagnostic imaging biomarker for multiple sclerosis (MS). FLAIR* is a combined MRI contrast that provides high conspicuity for CVS at 3 Tesla (3T), enabling its sensitive and accurate detection in clinical settings. This study evaluated whether CVS conspicuity of 3T FLAIR* is reliable across imaging sites and MRI vendors and whether gadolinium (Gd) contrast increases CVS conspicuity.

Methods

A cross‐sectional, multicenter study recruited adults referred for possible diagnosis of MS at 10 sites. FLAIR* contrast was generated using high‐resolution T2*‐weighted (acquired pre‐ and post‐injection of Gd) and T2‐weighted fluid‐attenuated inversion recovery (T2‐FLAIR) brain images at 3T from two MRI vendors. Lesions and veins were segmented to compute lesion‐to‐vein contrast‐to‐noise ratio (CNR lesion‐to‐vein ), a quantitative measure of CVS conspicuity. CNR lesion‐to‐vein measures for pre‐ and post‐Gd FLAIR* were compared across sites and vendors.

Results

Eighty‐seven participants from nine sites were included in the analysis. There was no significant difference in mean CNR lesion‐to‐vein between sites for pre‐Gd ( p ‐value = 0.07) or post‐Gd ( p ‐value = 0.27) FLAIR*. There were also no significant differences between vendors for pre‐Gd ( p ‐value = 0.10) or post‐Gd ( p ‐value = 0.31) FLAIR*. Patient‐level pairwise differences in CNR lesion‐to‐vein between pre‐Gd and post‐Gd FLAIR* revealed a significant increase for post‐Gd FLAIR* ( p ‐value < 0.001).

Conclusions

CVS conspicuity on 3T FLAIR* is consistent across imaging sites and MRI vendors. Moreover, Gd‐based contrast agent significantly improved CVS conspicuity on 3T FLAIR*. These findings support the implementation of FLAIR* in clinical settings for MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisMagnetic Resonance ImagingCerebral VeinsBrainHumansMaleFemaleCross-Sectional StudiesReproducibility of ResultsAdultMiddle AgedContrast MediaAgedGadolinium

Stichwörter der Autor:innen

FLAIR*MRIcentral vein signmulticentermultiple sclerosismultivendor

Substanzen

Contrast MediaGadolinium

Autor:innen und Institutionen

  • Penn Statistics in Imaging and Visualization Endeavor, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, USA.
  • QMENTA Inc., Boston, Massachusetts, USA.

ORCID-Profile: Paulo Rodrigues, Peter Calabresi, Nico Papinutto, Matthew K Schindler, Elias S Sotirchos, Pascal Sati

Zitieren

APA

Martin, M. L., Cao, Q., Luskin, E., Renner, B., Daboul, L., O'Donnell, C. M., Rodrigues, P., Derbyshire, J., Azevedo, C. J., Bar-Or, A., Caverzasi, E., Calabresi, P., Cree, B. A. C., Freeman, L., Henry, R. G., Longbrake, E. E., Oh, J., Papinutto, N., Pelletier, D., …, & Sati, P. (2025). Reliability of Central Vein Sign Imaging With 3T FLAIR* in a Multicenter Study. Journal of Neuroimaging. https://doi.org/10.1111/jon.70011

Vancouver

Martin ML, Cao Q, Luskin E, Renner B, Daboul L, O'Donnell CM, et al. Reliability of Central Vein Sign Imaging With 3T FLAIR* in a Multicenter Study. Journal of Neuroimaging. 2025. doi:10.1111/jon.70011

BibTeX
@article{Martin2025,
  author = {Martin, Melissa Lynne and Cao, Quy and Luskin, Elaina and Renner, Brian and Daboul, Lynn and O'Donnell, Carly M and Rodrigues, Paulo and Derbyshire, John and Azevedo, Christina J and Bar-Or, Amit and Caverzasi, Eduardo and Calabresi, Peter and Cree, Bruce A C and Freeman, Léorah and Henry, Roland G and Longbrake, Erin E and Oh, Jiwon and Papinutto, Nico and Pelletier, Daniel and Prchkovska, Vesna and Ramos, Marc and Samudralwar, Rohini D and Schindler, Matthew K and Sotirchos, Elias S and Sicotte, Nancy L and Solomon, Andrew J and Reich, Daniel S and Ontaneda, Daniel and Shinohara, Russell T and Sati, Pascal},
  title = {Reliability of Central Vein Sign Imaging With 3T FLAIR* in a Multicenter Study},
  journal = {Journal of Neuroimaging},
  year = {2025},
  doi = {10.1111/jon.70011}
}
Kostenlos starten →